# Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)

> **NCT06235281** · EARLY_PHASE1 · SUSPENDED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 20 (estimated)

## Conditions studied

- Mycosis Fungoides

## Interventions

- **DRUG:** Mogamulizumab-Kpkc
- **DEVICE:** Phototherapy

## Key facts

- **NCT ID:** NCT06235281
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2024-01-18
- **Primary completion:** 2026-09-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** Slow Accrual
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06235281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06235281, "Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06235281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*